Citations (4)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Alexander V. van Schoonhoven, Marcel H. Schöttler, Erik H. Serné, Patrick P.G Schrömbges, Maarten J. Postma & Cornelis Boersma. (2023) The health and budget impact of sodium-glucose co-transporter-2 inhibitors (SGLT2is) in The Netherlands. Journal of Medical Economics 26:1, pages 547-553.
Read now
Read now
Articles from other publishers (3)
Stijn Crutzen, Gert Baas, Petra Denig, Mette Heringa & Katja Taxis. (2023) Pharmacist-led intervention aimed at deprescribing and appropriate use of cardiometabolic medication among people with type 2 diabetes. Research in Social and Administrative Pharmacy 19:5, pages 783-792.
Crossref
Crossref
Scott J. Pilla, Kayla A. Meza, Nancy L. Schoenborn, Cynthia M. Boyd, Nisa M. Maruthur & Geetanjali Chander. (2022) A Qualitative Study of Perspectives of Older Adults on Deintensifying Diabetes Medications. Journal of General Internal Medicine 38:4, pages 1008-1015.
Crossref
Crossref
Samuel Seidu, Mansha Seewoodharry & Kamlesh Khunti. (2021) De-intensification in older people with type 2 diabetes: why, when and for whom?. The Lancet Healthy Longevity 2:9, pages e531-e532.
Crossref
Crossref